Published in
Elsevier, Journal of Infection, 6(84), p. 795-813, 2022
DOI: 10.1016/j.jinf.2022.04.018
Links
Tools
Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.
Journal article published in 2022 by
Xinxue Liu,
Alasdair P. S. Munro,
Shuo Feng,
Leila Janani,
Parvinder K. Aley,
Gavin Babbage,
David Baxter,
Marcin Bula,
Katrina Cathie 
,
Krishna Chatterjee,
Wanwisa Dejnirattisai,
Kate Dodd,
Yvanne Enever,
Ehsaan Qureshi,
Anna L. Goodman
and other authors.
,
Krishna Chatterjee,
Wanwisa Dejnirattisai,
Kate Dodd,
Yvanne Enever,
Ehsaan Qureshi,
Anna L. Goodman
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 